A detailed history of Wellington Management Group LLP transactions in Ocugen, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 507,495 shares of OCGN stock, worth $370,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares
507,495
Previous 459,102 10.54%
Holding current value
$370,471
Previous $454,000 10.79%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$0.72 - $1.08 $34,842 - $52,264
48,393 Added 10.54%
507,495 $405,000
Q3 2024

Nov 14, 2024

BUY
$0.98 - $1.95 $449,919 - $895,248
459,102 New
459,102 $454,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $158M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.